The floor price of Rs 1,000 is at a discount of 18.57% to the previous day's closing price of Rs 1,228.05 on the BSE.

Through the OFS, Patanjali Ayurved proposes to sell up to 2.53 crore equity shares , which represents 7% stake, and in the case of oversubscription, the promoter is planning to sell additional 2%.

In an exchange filing, the company said, "The seller proposes to sell up to 2,53,39,640 equity shares of face value of Rs 2 each of the company (representing 7% of the total paid-up equity share capital) on 13 July 2023.”

The OFS will open on 13 July 2023, which is the T-day, where only non-retail investors can bid for the shares. On 14 July 2023, which is the T+1 day, the OFS will be accessible for retail investors and those non-retail investors, who choose to carry forward their un-allotted bids from T day.

The seller may also offload an additional 72.39 lakh shares, representing 2% of the total paid-up equity share capital. If the oversubscription option is exercised, the company will end up collectively offloading 3.25 crore shares, which represent 9% of the paid-up share capital.

About 25% of the offer is reserved for mutual funds and insurance companies. If there is any undersubscription in this category, the unsubscribed portion will be available to other bidders in the non-retail category. Jefferies India and IIFL Securities are acting as brokers for the offer.

Patanjali Foods (formerly known as Ruchi Soya Industries), is a diversified Indian conglomerate with strong focus on Fast Moving Consumer Goods (FMCG) and Fast Moving Health Goods (FMHG) segments.

The FMCG company's net profit rose 12.49% to Rs 263.71 crore on 18.15% increase in revenue from operations to Rs 7,872.92 crore in Q4 FY23 over Q4 FY22.